Cell surface alterations induced by the acycloguanosine (ACG) resistant and sensitive strains of herpes simplex virus type 2 (HSV-2) in the presence of ACG and tunicamycin.
HSV-2-ACG, a mutant of herpes simplex virus type 2, which is resistant to acycloguanosine and also capable of inducing fusion of BSC1 cells, was isolated. The viral-induced surface changes in these cells were studied using scanning electron microscopy. The formation of gigantic fused cells with increased number of microvilli and virus-like particles, extensively covering the infected cell surface, were investigated. Tunicamycin (50 micrograms/ml), an inhibitor of glycosylation of polypeptides, blocks the production of infectious virus, as well as the cell-fusion and efficiently prevents the viral induced alterations occurring on the surface of the cells.
D000212:Acyclovir / Q000633:toxicity*; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004352:Drug Resistance, Microbial; D005944:Glucosamine / Q000031:analogs & derivatives*; D007668:Kidney; D008855:Microscopy, Electron, Scanning; D018139:Simplexvirus / Q000187:drug effects / Q000235:genetics / Q000648:ultrastructure*; D013045:Species Specificity; D014415:Tunicamycin / Q000633:toxicity*
D014415:Tunicamycin; D005944:Glucosamine; D000212:Acyclovir